Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

ClinicalTrials.gov ID: NCT00042458

Public ClinicalTrials.gov record NCT00042458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Investigate the Safety of Pramlintide Treatment Employing Pramlintide Dose-Titration Followed by Insulin Dose Optimization in Subjects With Type 1 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Intensive Insulin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.

Study identification

NCT ID
NCT00042458
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
296 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Mar 2003 (Actual)
Completion
Mar 2003 (Actual)
Last update posted
Sep 23, 2015

2002 – 2003

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Ana Ventures LLC Mesa Arizona 85204 —
Phoenix Endocrinology Clinic, Ltd. Phoenix Arizona 85006 —
East Bay Clinical Trial Center Concord California — —
Valley Research Fresno California — —
UCSD Diabetes Research Center San Diego California — —
Diabetes Research Institute San Mateo California — —
Sansum Medical Research Institute Santa Barbara California — —
Diablo Clinical Research Walnut Creek California — —
Barbara Davis Center for Childhood Diabetes Denver Colorado 80262 —
MedStar Clinical Research Center Washington D.C. District of Columbia — —
Medical Research Unlimited Aventura Florida 33180 —
Medical Research Unlimited Aventura Florida — —
Internal Medicine Associates Fort Myers Florida — —
Suncoast Clinical Research New Port Richey Florida — —
Children's Clinic Tallahassee Florida — —
Atlanta Diabetes Associates Atlanta Georgia — —
St. James Diabetes Center Chicago Heights Illinois 60411 —
St. James Diabetes Center Chicago Heights Illinois — —
Indiana University Outpatient Clinical Research Indianapolis Indiana — —
University of Maryland Joslin Diabetes Center Baltimore Maryland 21012 —
Henry Ford Health System Detroit Michigan — —
Grand Rapids Associated Interns Grand Rapids Michigan — —
Radiant Research St Louis Missouri 63141 —
Mercury Street Medical Butte Montana — —
UNC Diabetes Care Center Durham North Carolina 27713 —
Ohio State Univ.-Division of Endocrinology, Diabetes Columbus Ohio 43210 —
Radiant Research Portland Oregon — —
Physicians for Clinical Research Camp Hill Pennsylvania — —
Vanderbilt University Medical Center Nashville Tennessee — —
North Texas Clinical Research Irving Texas — —
Private Practice Lufkin Texas 75904 —
Private Practice Lufkin Texas — —
Rainier Clinical Research Center Renton Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00042458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00042458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →